Opinion|Videos|April 26, 2024

Frontline Treatment for EGFR-Mutated Lung Cancer

An overview of frontline treatment options for patients with EGFR-mutated non–small cell lung cancer.

Episodes in this series

A panel of 4 experts on lung cancer

EP. 1 Biomarker Testing in Non–Small Cell Lung Cancer

A panel of 4 experts on lung cancer

EP. 2 NSCLC: Molecular Testing in the Metastatic Setting

Video 3 - "NGS Testing Challenges and Considerations in NSCLC"

EP. 3 NGS Testing Challenges and Considerations in NSCLC

Video 4 - "Frontline Treatment for EGFR-Mutated Lung Cancer"

EP. 4 Frontline Treatment for EGFR-Mutated Lung Cancer

A panel of 4 experts on lung cancer

EP. 5 FLAURA2: Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

A panel of 4 experts on lung cancer

EP. 6 MARIPOSA: First-Line Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC

Video 7 - "Second-Line Treatment of Patients With EGFR-Mutated NSCLC"

EP. 7 Second-Line Treatment of Patients With EGFR-Mutated NSCLC

video 8 - "Treatment Landscape for NSCLC With EGFR Exon 20 Insertion Mutations"

EP. 8 Treatment Landscape for NSCLC With EGFR Exon 20 Insertion Mutations

A panel of 4 experts on lung cancer

EP. 9 NSCLC with EGFR Exon 20 Insertions: Updated Data from PAPILLON

A panel of 4 experts on lung cancer

EP. 10 Unmet Needs and Future Perspectives on the Treatment of EGFR-Mutated NSCLC

EP. 11 Preferred Treatment Options for EGFRMutated Exon 20 Insertion+ NSCLC

EP. 11 Preferred Treatment Options for EGFRMutated Exon 20 Insertion+ NSCLC

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Related to this article

Chinmay Jani, MD, describes how he counsels patients with and without a smoking history on a lung cancer diagnosis.

November 7th, 2026

Changing Mindsets and Removing Guilt Surrounding Lung Cancer Diagnoses

Chinmay Jani, MD, describes how he counsels patients with and without a smoking history on a lung cancer diagnosis.

Chinmay Jani, MD, discusses ASCO 2026 data on lung cancer trends in younger adults and why this group has been overlooked.

November 6th, 2026

Young Adults With Lung Cancer Often Fall Outside Screening Guidelines

Chinmay Jani, MD, discusses ASCO 2026 data on lung cancer trends in younger adults and why this group has been overlooked.

Chinmay Jani, MD, explains how air pollution and asbestos contribute to lung cancer deaths beyond tobacco.

November 5th, 2026

Air Pollution Emerges as Second Leading Risk Factor for Lung Cancer Deaths

Chinmay Jani, MD, explains how air pollution and asbestos contribute to lung cancer deaths beyond tobacco.

Chinmay Jani, MD, highlights non-smoking risk factors, the impact of lung cancer on younger populations, and the value of comprehensive molecular testing.

November 2nd, 2026

How Do Risk Factors and Genomic Advances Impact Lung Cancer Detection?

Chinmay Jani, MD, highlights nonsmoking risk factors, the impact of lung cancer on younger populations, and the value of comprehensive molecular testing.

Trending on CancerNetwork

Anthracycline Chemo May Accelerate Biological Aging in Breast Cancer Survivors

CELMoDs With CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma

ASCENT-03: Sacituzumab Govitecan Versus Chemotherapy in First-Line Metastatic TNBC

Contextualizing MRD Negativity and PFS Across Treatment Regimens in Relapsed/Refractory Multiple Myeloma

Managing Hypoxia, Anemia, and Cardiac Toxicity With Belzutifan Plus Lenvatinib